PT Paragon Karya Perkasa Tbk (IDX:PKPK)

Verve Therapeutics Ratios and Metrics

Market cap in millions IDR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	732,000	942,000	432,000	154,800	117,600	32,400
Market Cap Growth	98.28%	118.06%	179.07%	31.63%	262.96%	-8.98%
Enterprise Value	719,318	1,112,981	224,263	177,701	144,290	70,643
Last Close Price	610.00	785.00	360.00	258.00	196.00	54.00
PE Ratio	21.79	142.83	-	-	-	1255.67
PS Ratio	1.51	3.85	7.47	5.83	38.21	1.87
PB Ratio	2.69	3.68	1.07	14.53	2.94	0.80
P/TBV Ratio	3.20	4.30	1.07	14.53	2.94	0.80
P/FCF Ratio	-	-	-	-	17.69	13.26
P/OCF Ratio	19.66	-	-	-	17.64	13.26
EV/Sales Ratio	1.48	4.55	3.88	6.69	46.88	4.08
EV/EBITDA Ratio	11.71	28.79	-	-	-	22.75
EV/EBIT Ratio	12.31	31.13	-	-	-	32.04
EV/FCF Ratio	-4.39	-	-	-	21.71	28.92
Debt / Equity Ratio	0.00	0.89	0.12	2.26	0.60	0.66
Debt / EBITDA Ratio	0.01	5.87	-	-	-	8.64
Debt / FCF Ratio	-	-	-	-	3.63	10.98
Asset Turnover	0.89	0.46	0.22	0.39	0.05	0.25
Inventory Turnover	-	-	-	-	-	154.58
Quick Ratio	0.20	0.29	3.83	0.60	13.09	3.58
Current Ratio	0.54	0.50	3.84	0.83	14.20	3.86
Return on Equity (ROE)	20.00%	4.81%	-2.94%	-116.10%	-2.18%	0.09%
Return on Assets (ROA)	6.73%	4.18%	-1.86%	-11.06%	-3.57%	1.96%
Return on Capital (ROIC)	12.90%	4.76%	-2.03%	-15.24%	-3.62%	2.00%
Return on Capital Employed (ROCE)	21.20%	13.80%	-	-	-	3.30%
Earnings Yield	4.59%	0.70%	-1.42%	-19.00%	-0.75%	0.08%
FCF Yield	-22.37%	-20.24%	-15.42%	-2.88%	5.65%	7.54%
Buyback Yield / Dilution	-1.70%	-36.45%	-46.58%	-	-	-11.24%

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.